China News
INTERN DAILY
Pharma giant AstraZeneca takes China probes 'very seriously'
Pharma giant AstraZeneca takes China probes 'very seriously'
by AFP Staff Writers
London (AFP) Nov 12, 2024

British pharmaceutical giant AstraZeneca on Tuesday said it takes "very seriously" China's investigations into potential illegal data collection and drug imports by the group that led to the detention of its China boss.

"We take the matters in China very seriously," chief executive Pascal Soriot said in a statement contained in the group's latest earnings release that revealed a small rise in net profit.

"If requested we will fully cooperate with the authorities. We remain committed to delivering innovative life-changing medicines to patients in China," he added.

The group last week confirmed Leon Wang, president of AstraZeneca China, had been detained.

China is a key market for AstraZeneca, developer of a Covid-19 jab widely administered throughout the world during the coronavirus pandemic.

AstraZeneca on Tuesday noted that China accounted for about 12 percent of its global revenues in the third quarter. Sales in the country jumped 15 percent in the July-September period.

"The company is aware of a number of individual investigations by the Chinese authorities into current and former AstraZeneca employees," the drugs giant added in the latest statement.

"To the best of the company's knowledge, the investigations include allegations of medical insurance fraud, illegal drug importation and personal information breaches."

AstraZeneca said it "has not received any notification that it is itself under investigation".

The probes involved five current and former employees of the firm -- all with Chinese citizenship -- which are being led by authorities in the southern city of Shenzhen, according to Bloomberg.

One investigation related to the firm's collection of patient data, which authorities suspect may have breached Chinese privacy laws, the financial newswire also reported, citing people with knowledge of the situation.

Another probe related to imports of a liver cancer drug that had not been approved in mainland China, according to Bloomberg.

UK-headquartered AstraZeneca has 90,000 employees globally.

Multinationals have faced an increasingly-difficult business environment in China in recent years, industry groups say, citing a lack of transparency on data laws and prolonged detentions of employees.

- US investment -

AstraZeneca on Tuesday added that profit after tax rose four percent in the third quarter to $1.4 billion from a year earlier.

Total revenue jumped 18 percent to $13.6 billion, "reflecting the increasing demand for our medicines across oncology, biopharmaceuticals and rare disease", said Soriot.

The group also announced $2-billion of new investment in its main market, the United States.

Shares in AstraZeneca were down 1.3 percent in midday deals on London's top-tier FTSE 100 index, which was trading one percent lower overall.

Its shares fell sharply when reports of Wang's detention emerged earlier this month, wiping billions of dollars off its valuation.

AstraZeneca's profits "upgrade puts the Chinese probe in perspective", noted Derren Nathan, head of equity research at Hargreaves Lansdown.

burs-bcp/ajb/db

Related Links
Hospital and Medical News at InternDaily.com

Subscribe Free To Our Daily Newsletters
Tweet

RELATED CONTENT
The following news reports may link to other Space Media Network websites.
INTERN DAILY
WHO chief says Lebanon health system 'struggling to cope'
Geneva (AFP) Oct 2, 2024
The World Health Organization chief warned Tuesday that Lebanon's health system was struggling to keep up, after Israel escalated airstrikes and launched ground raids into the country. "The death toll in Lebanon is rising, and hospitals are overwhelmed with the influx of injured patients," Tedros Adhanom Ghebreyesus warned on X. "The health system has been weakened by successive crises and is struggling to cope with the immense needs," he said, adding that WHO was scaling up its response. Is ... read more

INTERN DAILY
Shenzhou 18 crew back in China after 6-month mission to Tiangong station

Chinese space station crew returns after six months in orbit

Shenzhou XIX Crew Joins Tiangong Space Station for Crew Rotation

Three-person crew enters China's Tiangong space station

INTERN DAILY
Fears of Trump trade wars cast pall over Asia-Pacific summit

Asian markets drop as Trump worries kick in after China disappoints

China's 'Singles Day' shopping spree in spotlight as spending flags

China says to impose anti-dumping measures on EU brandy

INTERN DAILY
INTERN DAILY
World leaders praise Trump as he claims US election win

NATO chief congratulates Trump, says will keep alliance 'strong'

Myanmar junta chief to visit China for first time since coup

NATO will 'stay united' whoever wins US election: Rutte

INTERN DAILY
Rwanda counting on Russia to train nuclear power specialists

Framatome opens new Italian offices to bolster European nuclear energy growth

Small modular nuclear reactors may drive US energy and emissions progress

Building the materials for the next generation of nuclear reactor

INTERN DAILY
Germany arrests US man accused of offering to spy for China

China says ex-government worker to be executed for spying

Musk amplifies conservative voices in liberal Silicon Valley

Latvia jails taxi driver for 7 years for spying for Russia

INTERN DAILY
Rwanda counting on Russia to train nuclear power specialists

Framatome opens new Italian offices to bolster European nuclear energy growth

Small modular nuclear reactors may drive US energy and emissions progress

Building the materials for the next generation of nuclear reactor

INTERN DAILY
Sweden blocks 13 offshore wind farms over defence concerns

Sweden's defence concerned by planned offshore wind power

On US coast, wind power foes embrace 'Save the Whales' argument

Renewables revolt in Sardinia, Italy's coal-fired island

Subscribe Free To Our Daily Newsletters




The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.